Comparing four removable orthodontic devices and no orthodontic treatment in children with excessive overjet

ISRCTN ISRCTN12775595
DOI https://doi.org/10.1186/ISRCTN12775595
Secondary identifying numbers 0019079
Submission date
14/03/2020
Registration date
30/04/2020
Last edited
10/07/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Malocclusion means that the upper and lower teeth do not fit together well. This can cause problems with chewing and dental hygiene. Class II malocclusion (overjet) is where the upper jaw teeth are further forward than the lower jaw teeth. This is commonly caused by the lower jaw being underdeveloped or being positioned too far back. Class II malocclusion can be treated in growing children by wearing braces that encourage the lower jaw to grow or move forward. This study aims to compare three braces to eachother and to no treatment in correcting class II malocclusion in children before and during puberty.

Who can participate?
Children aged 17 years or under who need orthodontic treatment for class II malocclusion.

What does the study involve?
Participants who choose to delay wearing a brace will have X-rays at the start of the study and at 18 months. Those who choose to start treatment immediately will be randomly allocated to wear one of three braces. They will have X-rays at the start of the study and at the end of treatment.

What are the possible benefits and risks of participating?
Participants will benefit from correction of their malocclusion. There are no risks expected for those taking part in the study. The braces might be uncomfortable at the start.

Where is the study run from?
University of Turin Dental School (Italy)

When is the study starting and how long is it expected to run for?
June 2019 to December 2023

Who is funding the study?
University of Turin (Italy)

Who is the main contact?
Dr Serena Ravera, serenaravera@unito.it

Contact information

Dr Serena Ravera
Public

Dental School
Department of Surgical Sciences, Orthodontics Division
University of Turin
Via Nizza 230
Turin
10126
Italy

ORCiD logoORCID ID 0000-0003-2501-5172
Phone +39 0116331547
Email serenaravera@unito.it

Study information

Study designSingle-centre randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet ISRCTN12775595_PIS_19Mar2020.pdf
Scientific titleDento-skeletal effects of removable functional appliances in class II growing patients: a randomized controlled trial
Study acronymTERFAC2
Study objectivesThe aim of this study is to compare dento-skeletal effects of functional removable appliances in skeletal Class II malocclusion in growing patients at different stages of growth, according to cervical vertebral maturation method (CVM2 and CVM3), compared to untreated subjects.
Ethics approval(s)Approved 21/02/2020, Ethics Board of the City of Health And Science of Turin [Comitato Etico Interaziendale A.O.U. Città della Salute e della Scienza di Torino] (Corso Bramante 88/90, 10126 Turin, Italy; +39 011 6331633; comitatoetico@cittadellasalute.to.it ), ref: 000127/2019
Health condition(s) or problem(s) studiedMalocclusion
InterventionCurrent interventions as of 19/01/2023:
In this randomized controlled trial, the sample will be composed of 4 arms: no treatment (patients that autonomously choose to delay the treatment), and 3 randomly assigned treatment arms (EF myofunctional device, Invisalign with mandibular advancement feature, Function Generating Bite arm, Twin Block arm) comprising 15 Caucasian growing class II subjects for each arm. The randomization will be generated using Randomizer software.

Previous interventions:
In this randomized controlled trial, the sample will be composed of 4 arms: no treatment (patients that autonomously choose to delay the treatment), and 3 randomly assigned treatment arms (EF myofunctional device, Invisalign with mandibular advancement feature, Function Generating Bite arm) comprising 15 Caucasian growing class II subjects for each arm. The randomization will be generated using Randomizer software.


Within the group treated, there will be two subgroups according to the cervical vertebrae maturation (CVM) stage of growth at the beginning of treatment (T0): 8 patients at CVM2 stage of growth (pre-pubertal) and 8 patients at CVM3 stage of growth (pubertal). The same criteria will be adopted for the control group.

The average duration of treatment will be 18 months. The participants will use the devices until the malocclusion is corrected. All the devices are removable, i.e. they can be taken out of the mouth.

Cephalometric analysis
For each patient included in the study, lateral radiographs will be collected both at the beginning (T0) and at the end of the treatment (T1). If the X-rays will be performed with different machines, it will be necessary to calibrate the images before starting the cephalometric tracings.
An orthodontic software (Dolphin Imaging & Management Solutions, at Patterson Technology, Verona, Italy) will be used to standardize the X-rays and perform the cephalometric tracings at T0 and T1.
From a skeletal point of view the cephalometric values analyzed will be: SN^GoGn, SpP^GoGn, SNA, SNB, ANB, A Downs, B Downs, A:Po, Wits Index, ArGo^Gn together with the linear mandibular measurement Go:Co, Gn:Co, Gn:Go.
From the dental point of view the attention will be focused on the incisor sector level and therefore 11^SpP, 41^GoGn and 11^41.
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)1. FGB (Function Generating Bite) 2. Invisalign® Mandibular Advancement Feature (MAF; Align Technology, Santa Clara, CA, USA) 3. EF Educatore Funzionale (OrthoPlus, Igny, France) 4. TWIN BLOCK (added 19/01/2023)
Primary outcome measure1. SN^GoGn
2. SpP^GoGn
3. SNA
4. SNB
5. ANB
6. A Downs
7. B Downs
8. A:Po
9. Wits Index
10. ArGo^Gn
11. Go:Co
12. Gn:Co
13. Gn:Go
14. 11^SpP
15. 41^GoGn
16. 11^41

All parameters will be calculated by analysing lateral radiographs taken before treatment and at the end of treatment.
Secondary outcome measuresPuberty stage of participant
Overall study start date03/06/2019
Completion date06/12/2023

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit8 Years
Upper age limit17 Years
SexBoth
Target number of participants60
Key inclusion criteria1. Divergence between cranial base and mandibular plane within normal limits (SN^GoGn <37°)
2. Moderate crowding in the upper arch (≤4 mm)
3. Good patient compliance (18-22 h per day)
4. Excellent radiographic record quality, with adequate cephalometric point display and head rotation control
5. Aged 8-17 years
Key exclusion criteria1. Severe transverse dental or skeletal discrepancies
2. Severe vertical dental or skeletal discrepancies
3. Extraction treatments
4. Temporomandibular disorders (TMDs)
5. Periodontal disease
Date of first enrolment06/07/2020
Date of final enrolment06/07/2023

Locations

Countries of recruitment

  • Italy

Study participating centre

University of Turin Dental School
Via Nizza 230
Turin
10126
Italy

Sponsor information

University of Turin
University/education

Via Nizza 230
Turin
10126
Italy

Phone +39 01163354
Email segr_cirdental@unito.it
Website http://en.unito.it/
ROR logo "ROR" https://ror.org/048tbm396

Funders

Funder type

University/education

Università degli Studi di Torino
Government organisation / Universities (academic only)
Alternative name(s)
University of Turin in Italy, University of Turin, Italy, Università di Torino, 都灵大学, University of Turin, UNITO
Location
Italy

Results and Publications

Intention to publish date06/12/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository, Published as a supplement to the results publication
Publication and dissemination planPlanned publication in a high-impact peer reviewed journals in 2024.
IPD sharing planCurrent IPD sharing statement as of 23/01/2023:
The datasets generated during and/or analysed during the current study will be stored in a publically repository (Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino Corso Bramante 88/90 and C.I.R. DENTAL SCHOOL. The Responsible for Data Protection or “Data Protection Officer” (“DPO”) is available at dpo@cittadellasalute.to.it).
The datasets generated and/or analysed during the current study will be published as a supplement to the results publication.

Previous IPD sharing statement:
The datasets generated and/or analysed during this study will be included in the subsequent results publication

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 19/03/2020 30/04/2020 No Yes

Additional files

ISRCTN12775595_PIS_19Mar2020.pdf
uploaded 30/04/2020

Editorial Notes

10/07/2023: The scientific contact was removed.
23/01/2023: IPD sharing statement updated.
19/01/2023: The following changes were made to the trial record:
1. The public title was changed from 'Comparing three removable orthodontic devices and no orthodontic treatment in children with excessive overjet' to 'Comparing four removable orthodontic devices and no orthodontic treatment in children with excessive overjet'.
2. The interventions and drug names were updated.
30/04/2020: The participant information sheet was uploaded as an additional file.
19/03/2020: Trial's existence confirmed by Comitato Etico Interaziendale A.O.U. Città della Salute e della Scienza di Torino.